PP
CSTL icon

PDT Partners’s Castle Biosciences CSTL Stock Holding History

PDT Partners’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,351
Closed -$356K – 894
2021
Q3 		$356K Buy
5,351
+2,408
+82% +$169K 0.03% 556
2021
Q2 		$216K Sell
2,943
-7,715
-72% -$510K 0.01% 687
2021
Q1 		$730K Buy
+10,658
New +$801K 0.05% 424
2020
Q4 		– Sell
-4,716
Closed -$243K – 722
2020
Q3 		$243K Buy
+4,716
New +$210K 0.02% 590

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

PDT Partners's CSTL Position: Q4 2021 in Review

PDT Partners sold out of Castle Biosciences (CSTL) in Q4 2021, closing a stake of 5,351 shares — an estimated $356K sold.

PDT Partners first reported a position in CSTL in Q3 2020 and held it in 4 quarters. The position peaked at $730K in Q1 2021. 159 funds tracked by Wall St. Rank hold CSTL as of Q4 2021.

  • PDT Partners reported no remaining Castle Biosciences position as of Q4 2021 after selling out during the quarter.
  • PDT Partners sold 5,351 Castle Biosciences shares in Q4 2021, an estimated $356K.
  • PDT Partners first reported a position in Castle Biosciences in Q3 2020 and held it in 4 quarters.
  • PDT Partners's Castle Biosciences position peaked at $730K in Q1 2021.
  • 159 funds tracked by Wall St. Rank held Castle Biosciences as of Q4 2021.

Based on PDT Partners's 13F filing for Q4 2021, filed 14 Feb 2022.